
Flesh-eating bacteria kill four in Florida after terrifying surge in infections... how to stay safe
The Florida Department of Health announced this week that four residents have died from vibrio vulnificus, a flesh-eating bacteria found in coastal waters.
Another nine cases have been confirmed this year, the department said. Last year, 82 cases and 19 deaths occurred in the state, which officials said is due to the impact of Hurricane Ian.
Deaths this year occurred in Bay, Broward, Hillsborough and St Johns counties, all of which are found on the Florida coasts.
No further information has been released about the victims.
Vibrio vulnificus enters the body through even the smallest of scrapes, infiltrating the bloodstream. From there, it releases enzymes and toxins that break down proteins, fats and collagen, destroying skin and muscle tissue.
It also evades the immune system's defenses while triggering a widespread inflammatory response that causes even more tissue damage. Reduced blood flow to the infected area worsens this damage, ultimately leading to the death of tissue beneath the skin.
This results in amputations to try and cut away the infection or, in severe cases, death.
Vibrio requires warm water to grow and proliferate, making the southern coasts prime breeding grounds.
However, colder regions are becoming gradually more hospitable as ocean temperatures rise, attracting and nurturing colonies of the bacteria.
Vibrio infections have been confirmed on the East coast, Alaska, the Baltic Sea, and Chile, which scientists now believe could be the next hotspots.
The CDC has not issued an annual report on vibrio in the US since 2019, when 2,685 infections were reported.
Previous reviews on East Coast states from 1988 through 2018 showed vibrio wound infections increased eightfold, from about 10 cases to more than 80 annually.
Vibrio vulnificus can also infect a person who eats raw or undercooked shellfish, causing painful abdominal cramps and diarrhea, and, in cases where the bacteria enter the bloodstream, sepsis and death.
The CDC estimates that 80,000 Americans are infected with vibrio every year, although there are only 1,200 to 2,000 confirmed cases annually, as it is often misdiagnosed.
Vibriosis, the infection caused by the bacteria, is typically treated with antibiotics, specifically doxycycline and ceftazidime.
Once the bacteria reach the bloodstream, the infection is fatal about 50 percent of the time.
The threat from the insidious bacteria is only growing, scientists say.
Sky-high seafood consumption around the world, using coastal waters for recreational activities, and the compounding effects of global climate change are setting humans up to see a marked increase in both reported cases and fatalities in the near future,' according to scientists from the UK and Spain.
The vast majority of vibrio infections have occurred in Florida, tied to post-hurricane flooding, and Texas, largely due to fishing and oyster harvesting injuries, as well as Alabama, Mississippi, and Louisiana.
The Florida Department of Health warned residents: 'Water and wounds do not mix. Do not enter the water if you have fresh cuts or scrapes.'
Officials also urged people who are immunocompromised to wear protective footwear to prevent cuts or injuries on the beach.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
an hour ago
- Telegraph
China is preparing to steal the jobs of the future
They call it 'artificial general intelligence' (AGI) and it may be only a matter of a few years away. AGI is the imagined point at which computers finally achieve consciousness, surpass human intelligence and begin to self-improve across virtually all cognitive tasks at an accelerating rate. Sometimes referred to as the 'singularity', it's long been the stuff of science fiction, but many techies believe, such is the pace of current development, that it is on the verge of becoming a reality. Whoever gets there first, it is widely believed, will inherit the Earth, embedding their influence, ideology and systems of governance into world affairs for generations to come. It's a frightening as well as awe-inspiring prospect and it is one whose potentially transformational geopolitical consequences are only now starting to be more widely appreciated. And it's why the US and China are increasingly engaged in what can only be described as a new arms race – or space race – to develop and harness artificial superintelligence for economic and geopolitical superiority. In both jurisdictions, hundreds of billions of dollars a year are being poured into getting there first. Yet though the Trump administration is only too aware of the threat, its response is oddly backward-looking and counterproductive. Despite the apparent world lead the US has in supercomputing, there is a high chance it will end up losing the war.


Telegraph
2 hours ago
- Telegraph
The healthcare sector is unloved – this trust is a prime example
Questor is The Telegraph's stock-picking column, helping you decode the markets and offering insights on where to invest. Questor believes the healthcare sector is looking unloved at the moment. Sven Borho, the co-manager of Worldwide Healthcare Trust, the largest investment trust focused on the sector, agrees. In fact, he thinks the sector has been out of favour for most of the past decade. Borho puts the blame for this squarely on the US debate around drug pricing, and while Questor agrees that it has had a big impact on sentiment, so too has the shift from the low inflation/low interest rate environment that prevailed before 2022. While there had been mutterings about drug prices for a long time, it was a tweet by Hillary Clinton in September 2015, who was then on the campaign trail, that sparked an upset in the sector. She was promising to tackle price-gouging in the speciality drug market, which set the ball rolling on a series of measures from both sides of the US political divide. Recently, this has culminated in President Trump's May 2025 executive order aimed at bringing US prices for patented drugs down to the levels charged in other countries. Last week's threat of a 200pc tariff on imports of drugs manufactured outside the US is another complicating factor. However, Borho feels that investors have tended to be overly negative in response to threats to control drug prices. He also observes that, historically, Republican presidents have been good for the sector. The Trump administration's choices for the heads of the various Federal healthcare bodies may have been controversial, but Borho's sense is that bodies such as the Food and Drug Administration (FDA) are becoming more efficient. In recent years, the trust's high exposure to biotech companies has weighed on its performance. As outlined in this column's recent appraisal of RTW Biotech Opportunities, the biotech sector suffers not only from political pressures but a low sentiment from an investor base currently wary of loss-making and unproven companies – unfortunately, the bread and butter of the biotech industry. Nevertheless, Borho is keen to stick with this approach as he believes that, over the long run, capturing the benefits of innovation is key to generating outsized returns. He points out that biotech companies were responsible for almost two thirds of all clinical trials that began last year and most – 85pc – of the novel products approved. At the same time, many big pharmaceutical companies face the prospect of lucrative products coming off patent and these companies need to acquire promising biotech businesses to maintain their revenue lines. Relative to its benchmark, Worldwide Healthcare is underweight big pharma, which was 40pc of the MSCI index at the end of June but 18pc of the trust's portfolio – it had a corresponding overweight exposure to biotech. However, there are also exciting developments in areas beyond biotech. Over Worldwide Healthcare's latest financial year, some of the strongest contributors to its returns were medical equipment companies, including Boston Scientific and Intuitive Surgical. Boston Scientific has been making great strides in the cardiovascular field, while Intuitive Surgical's da Vinci robotic surgery equipment is delivering better surgical outcomes for patients. Medical technology and devices accounted for a third of the trust's portfolio at the end of June. Worldwide Healthcare turned 30 in April, and was one the best-performing trusts over that period, offering a total return of about 4,000pc. However, over the past five years, the trust has lost money for shareholders. Unsurprisingly, that has put pressure on its share price discount to net asset value. The board says that it will buy back stock when the discount is wider than 6pc, but for most of the past 12 months the discount has been in double digits, which opened the door to activist Saba to build a 5pc stake in the trust. The board has stepped up the pace of share buybacks and both the discount and Saba's stake appear to be coming down now. Questor agrees with the manager that there is plenty to get excited about in the healthcare sector over the next few years. Borho foresees a time when most cancer is treated as a chronic disease and much is curable. He predicts advances in the area of neurodegenerative disease such as Alzheimer's and Parkinson's to help improve and extend lives and hopes new gene therapies will cure rare diseases. He also thinks that artificial intelligence will help guide diagnoses, relieving pressure on GPs. Other trusts with a similar remit have done a better job of navigating this difficult period for the sector, so the big question is whether Worldwide Healthcare is the best way to take advantage of this theme. While the jury is out, the successful history of the trust can't be ignored. Questor says: hold Ticker: WWH Share price: £3.07


The Independent
7 hours ago
- The Independent
Trump says Coca-Cola agreed to use ‘real' cane sugar in US products
Donald Trump announced that Coca-Cola had agreed to use real cane sugar in its US products, claiming it would be a significant improvement. Currently, Coca-Cola in the US is made with high-fructose corn syrup, whereas cane sugar is utilized in other countries, including Mexico. A Coca-Cola representative responded by stating they appreciate Trump's enthusiasm and would soon share details on new innovative offerings, without directly confirming the cane sugar agreement. This move aligns with a broader 'Make America Healthy Again' initiative, which aims to combat chronic illness through wholesome food and environmental toxin elimination. Kennedy intends for the Food and Drug Administration to phase out the use of petroleum-based synthetic dyes in the nation's food supply, as seen in a recent pledge made by 40 US ice cream producers.